IAA30 Antibody

What is IAA30 and why is it important in plant research?

IAA30 is a member of the Aux/IAA protein family, which functions as transcriptional repressors in auxin signaling pathways. These proteins play crucial roles in plant growth and development by regulating gene expression in response to the plant hormone auxin (indole-3-acetic acid or IAA). IAA30 specifically is important because it helps mediate auxin responses that control various developmental processes including root formation, vascular development, and stress responses .

The study of IAA30 is particularly valuable for understanding hormone signal transduction in plants. Unlike some other Aux/IAA proteins, IAA30 has unique structural features that affect its stability and interaction with other proteins in the auxin signaling pathway. Research using IAA30 antibodies allows scientists to track the expression, localization, and modification of this protein under different developmental and environmental conditions .

What are the best methods for sample preparation when using IAA30 antibodies?

Proper sample preparation is critical for successful detection of IAA30 proteins. Based on established protocols, researchers should consider the following methodology:

• Tissue collection and homogenization:

  • Collect fresh plant tissue (preferably young, actively growing tissue where auxin signaling is active)

  • Flash-freeze in liquid nitrogen and grind to a fine powder using a pre-chilled mortar and pestle

  • Maintain cold temperatures throughout to prevent protein degradation

• Protein extraction buffer optimization:

  • Use extraction buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Igepal CA-630 (Nonidet P-40), 50 mM KCl, 20 mM MgCl₂, and protease inhibitor cocktail

  • Consider redox conditions carefully: supplement buffer with either 10 mM DTT (reducing conditions) or 10 mM Diamide (oxidizing conditions) depending on experimental goals

  • For IAA30 specifically, reducing conditions may be preferable to preserve protein structure

• Fixation for immunolocalization:

  • For tissue sections, fix samples in 4% EDAC in MTSB for 20 minutes followed by 30 minutes in 4% EDAC + 2% Formaldehyde

  • For seedlings, similar fixation protocols can be used before sectioning

These methods enhance epitope accessibility while preserving protein integrity, critical for antibody recognition of IAA30 .

What detection methods work best with IAA30 antibodies?

Several detection methods can be employed with IAA30 antibodies, each with specific advantages depending on research questions:

• Western Blotting:

  • Recommended for quantitative analysis and protein size confirmation

  • Use 10% SDS-PAGE gels for optimal separation

  • Transfer to PVDF membranes at 25V for 2 hours for best results

  • Dilution ratio: 1:5000-1:10,000 for primary antibody incubation

• Immunolocalization/Immunofluorescence:

  • Ideal for cellular and subcellular localization studies

  • Recommended dilution: 1:100-1:600 for primary antibody

  • Secondary antibody recommendation: Anti-rabbit IgG conjugated with fluorophores like DyLight® 549

  • Include negative controls (secondary antibody only and pre-immune serum) to validate specificity

• ELISA:

  • Useful for high-throughput quantitative analysis

  • Recommended dilution: 1:5000-1:10,000

  • Standard curve preparation is essential for accurate quantification

The selected method should align with specific research objectives, whether identifying protein expression patterns, quantifying protein levels, or determining subcellular localization .

How can I confirm the specificity of my IAA30 antibody?

Confirming antibody specificity is crucial for reliable research outcomes. Implement these methodological approaches:

• Molecular weight verification:

  • Run Western blots with positive controls (recombinant IAA30 protein)

  • Verify that detected bands match the expected molecular weight of IAA30

• Negative controls:

  • Test samples from IAA30 knockout mutants (if available)

  • Pre-absorption test: Pre-incubate antibody with excess synthetic IAA30 peptide or recombinant protein before immunodetection

  • If the signal disappears after pre-absorption, this confirms specificity

• Cross-reactivity assessment:

  • Test antibody against multiple plant species or tissues known to express or not express IAA30

  • Test against closely related Aux/IAA proteins to assess potential cross-reactivity

  • Document reactivity patterns similar to: "Confirmed reactivity in Arabidopsis thaliana; predicted reactivity in other dicots"

• Immunoprecipitation validation:

  • Perform IP followed by mass spectrometry to identify pulled-down proteins

  • Confirm the presence of IAA30 and document any co-precipitating proteins

Comprehensive validation ensures experimental integrity and supports the reliability of downstream analyses .

How do redox conditions affect IAA30 antibody binding and protein multimerization?

Redox conditions significantly impact IAA30 protein structure and, consequently, antibody binding efficiency. Research has revealed that Aux/IAA proteins, including IAA30, can undergo redox-dependent multimerization that affects their function and detectability:

• Reducing vs. oxidizing conditions:

  • Under reducing conditions (with DTT), IAA30 predominantly exists in monomeric form

  • Under oxidizing conditions (with Diamide), multimerization may occur through disulfide bond formation

  • This structural change can mask or expose epitopes, affecting antibody recognition

• Experimental approach to study redox sensitivity:

  • Perform parallel immunoprecipitations under different redox conditions:
    a) Extract proteins in buffer with 10 mM DTT (reducing)
    b) Extract proteins in buffer with 10 mM Diamide (oxidizing)
    c) Extract without redox agents (native conditions)

  • Analyze samples using non-reducing SDS-PAGE (without β-Mercaptoethanol) to preserve disulfide bonds

  • Compare with reducing SDS-PAGE to identify redox-dependent complexes

• DTT titration assay for redox sensitivity assessment:

  • Extract proteins in non-reducing conditions

  • Split samples and treat with increasing concentrations of DTT (0-10 mM)

  • Analyze by immunoblotting to observe transition from multimeric to monomeric forms

This redox sensitivity has functional implications for IAA30's role in auxin signaling and must be considered when designing experiments and interpreting results .

What are the best approaches for detecting IAA30 interactions with other proteins in vivo?

Understanding IAA30's interaction partners is crucial for elucidating its function in auxin signaling networks. Several advanced methodological approaches can be employed:

• Co-immunoprecipitation (Co-IP) with IAA30 antibodies:

  • Use crosslinking agents like formaldehyde (1%) to stabilize transient interactions

  • Perform IP with IAA30 antibodies followed by mass spectrometry to identify binding partners

  • Critical control: parallel IP with pre-immune serum or IgG

  • Validation: Reverse Co-IP using antibodies against identified partners

• Proximity-dependent labeling methods:

  • Express IAA30 fused to enzymes like BioID or TurboID in plant cells

  • These enzymes biotinylate nearby proteins, which can then be purified and identified

  • Advantage: Can capture transient or weak interactions that might be lost during traditional Co-IP

• Förster Resonance Energy Transfer (FRET) microscopy:

  • Create IAA30 fusions with fluorescent proteins (e.g., YFP)

  • Co-express potential interacting partners tagged with complementary fluorophores (e.g., CFP)

  • Measure energy transfer as evidence of protein proximity (<10 nm)

  • Useful for confirming interactions in specific cellular compartments

• Split-ubiquitin or split-luciferase complementation assays:

  • Fuse IAA30 to one half of the reporter protein and potential interactors to the other half

  • Reconstitution of reporter activity indicates interaction

  • Particularly useful for membrane-bound or nuclear interactions

When implementing these methods, consider that IAA30 interactions may be condition-dependent, transient, and affected by post-translational modifications or redox state .

How can I analyze IAA30 protein dynamics and turnover using antibody-based approaches?

IAA30, like other Aux/IAA proteins, undergoes rapid turnover in response to auxin. Analyzing these dynamics requires sophisticated experimental approaches:

• Cycloheximide chase assays with immunoblotting:

  • Treat plant tissues with cycloheximide to block protein synthesis

  • Collect samples at regular intervals (0, 15, 30, 60, 120 minutes)

  • Perform Western blotting with IAA30 antibodies

  • Quantify band intensity to determine protein half-life

  • Compare control vs. auxin-treated samples to assess auxin-induced degradation

• Pulse-chase immunoprecipitation:

  • Label newly synthesized proteins with 35S-methionine

  • Chase with unlabeled methionine with or without auxin treatment

  • Immunoprecipitate IAA30 at different time points

  • Analyze by SDS-PAGE and autoradiography

  • Calculate degradation rates under different conditions

• Fluorescence recovery after photobleaching (FRAP) with antibody labeling:

  • Create IAA30-fluorescent protein fusions

  • Photobleach a defined region and monitor fluorescence recovery

  • Use fixed cells and IAA30 antibodies to validate the dynamics observed in live cells

  • Calculate diffusion and exchange rates

• Proteasome inhibition studies:

  • Treat samples with proteasome inhibitors (MG132) with or without auxin

  • Analyze IAA30 levels by immunoblotting

  • Quantify the accumulation of IAA30 to assess proteasome-dependent degradation

These approaches enable quantitative assessment of IAA30 stability and auxin-mediated degradation, providing insights into its regulatory mechanisms .

What strategies can be used to analyze post-translational modifications of IAA30 using antibodies?

Post-translational modifications (PTMs) of IAA30 significantly influence its function, stability, and interactions. Detection and characterization of these modifications require specialized approaches:

• Phosphorylation analysis:

  • Immunoprecipitate IAA30 using validated antibodies

  • Analyze by phospho-specific staining (ProQ Diamond) or phospho-specific antibodies

  • For detailed analysis, perform IP followed by mass spectrometry

  • Compare samples treated with phosphatase inhibitors vs. phosphatase treatment

  • Lambda phosphatase treatment serves as a negative control

• Ubiquitination detection:

  • Co-immunoprecipitate IAA30 under native conditions

  • Perform Western blotting with anti-ubiquitin antibodies

  • Alternatively, express His-tagged ubiquitin and purify ubiquitinated proteins

  • Detect IAA30 in the purified fraction using IAA30 antibodies

  • Compare samples with and without proteasome inhibitors (MG132)

• SUMOylation analysis:

  • Immunoprecipitate IAA30

  • Perform Western blotting with anti-SUMO antibodies

  • Alternatively, perform in vitro SUMOylation assays with recombinant IAA30

  • Determine SUMO attachment sites by mass spectrometry

• Redox modification analysis:

  • Treat samples with alkylating agents (NEM or iodoacetamide) to block free thiols

  • Perform non-reducing vs. reducing SDS-PAGE followed by immunoblotting

  • Differences in migration patterns indicate the presence of disulfide bonds

  • For detailed analysis, use mass spectrometry to identify specific cysteine modifications

Understanding these modifications provides crucial insights into the regulation of IAA30 function in auxin signaling networks .

How can I use IAA30 antibodies to study protein-DNA interactions and transcriptional regulation?

IAA30, as a transcriptional regulator, interacts with DNA through its association with Auxin Response Factors (ARFs). Studying these interactions requires specialized techniques:

• Chromatin Immunoprecipitation (ChIP) using IAA30 antibodies:

  • Crosslink proteins to DNA using formaldehyde (1%, 10 minutes)

  • Sonicate chromatin to 200-500 bp fragments

  • Immunoprecipitate with IAA30 antibodies

  • Analyze precipitated DNA by qPCR or sequencing (ChIP-seq)

  • Expected results: Enrichment of auxin-responsive promoter regions

  • Essential control: ChIP with pre-immune serum or IgG

• Sequential ChIP (ChIP-reChIP) for protein complexes:

  • Perform first ChIP with IAA30 antibodies

  • Elute the complexes and perform a second ChIP with antibodies against potential partners (ARFs, TPL)

  • This confirms the presence of specific protein complexes on DNA

• Electrophoretic Mobility Shift Assay (EMSA) with IAA30 antibodies:

  • Prepare nuclear extracts from plant tissues

  • Incubate with labeled DNA probes containing auxin-responsive elements

  • Add IAA30 antibodies to the reaction

  • If IAA30 is part of the DNA-binding complex, antibody addition will cause a supershift

  • Control: Use pre-immune serum instead of specific antibodies

• Proximity Ligation Assay (PLA) for in situ detection:

  • Use IAA30 antibodies and antibodies against DNA-binding partners

  • Apply secondary antibodies with attached oligonucleotides

  • When proteins are in close proximity, oligonucleotides can be ligated and amplified

  • Visualize interaction sites in fixed cells or tissues

These approaches provide comprehensive insights into IAA30's role in transcriptional regulation and auxin-responsive gene expression .